Specifically, targeting JAK and STAT3 with WP1066 in GBM-associated stem cells can effectively lead to downregulation of HIF-1α and VEGF expression and reverse the hypoxic-induced immunosuppression [117] (Table 6). The gene discussed is STAT3; the disease is glioblastoma.